(Q44205624)

30 November 2017

title

Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia (English)

1 reference

30 November 2017

Raymond D Pratt

1

1 reference

30 November 2017

publication date

1 November 2002

1 reference

Journal of the Neurological Sciences

30 November 2017

published in

1 reference

30 November 2017

volume

203-204

1 reference

30 November 2017

page(s)

57-65

1 reference

Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Cerebral blood flow in dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Investigating the natural course and treatment of vascular dementia and Alzheimer's disease. Parallel study populations in two randomized, placebo-controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Frontal impairment in subcortical ischemic vascular dementia in comparison to Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

The clinical diagnosis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Course characteristics in the differentiation of dementia of the Alzheimer type and multi-infarct dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900266-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00266-6

1 reference

30 November 2017

1 reference